<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">najo</journal-id><journal-title-group><journal-title xml:lang="en">Nanosystems: Physics, Chemistry, Mathematics</journal-title><trans-title-group xml:lang="ru"><trans-title>Наносистемы: физика, химия, математика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-8054</issn><issn pub-type="epub">2305-7971</issn><publisher><publisher-name>Университет ИТМО</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17586/2220-8054-2024-15-2-260-267</article-id><article-id custom-type="elpub" pub-id-type="custom">najo-53</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CHEMISTRY AND MATERIALS SCIENCE</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ХИМИЯ И НАУКА О МАТЕРИАЛАХ</subject></subj-group></article-categories><title-group><article-title>Synthesis of redox-active Ce0.75Bi0.15Tb0.1F3 nanoparticles and their biocompatibility study in vitro</article-title><trans-title-group xml:lang="ru"><trans-title>Синтез редокс-активных наночастиц Ce0.75Bi0.15Tb0.1F3  и исследование их биосовместимости in vitro</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8431-4485</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чукавин</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chukavin</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чукавин Никита Николаевич.</p></bio><bio xml:lang="en"><p>Nikita N. Chukavin.</p><p>142290</p></bio><email xlink:type="simple">chukavinnik@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3391-7889</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колманович</surname><given-names>Д. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolmanovich</surname><given-names>D. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колманович Данил Дмитриевич.</p></bio><bio xml:lang="en"><p>Danil D. Kolmanovich.</p><p>142290</p></bio><email xlink:type="simple">kdd100996@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2725-8891</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филиппова</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Filippova</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Филиппова Арина Дмитриевна.</p></bio><bio xml:lang="en"><p>Arina D. Filippova.</p><p>Moscow, 119991</p></bio><email xlink:type="simple">arifilippova@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4820-8498</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Теплоногова</surname><given-names>М. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Teplonogova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Теплоногова Мария Александровна.</p></bio><bio xml:lang="en"><p>Maria A. Teplonogova.</p><p>Moscow, 119991</p></bio><email xlink:type="simple">m.teplonogova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2343-2140</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>V. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванов Владимир Константинович.</p></bio><bio xml:lang="en"><p>Vladimir K. Ivanov.</p><p>Moscow, 119991</p></bio><email xlink:type="simple">van@igic.ras.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2643-4846</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попов</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Popov</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Попов Антон Леонидович.</p></bio><bio xml:lang="en"><p>Anton L. Popov.</p><p>142290</p></bio><email xlink:type="simple">antonpopovleonid@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="en" id="aff-1"><institution>Institute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff><aff xml:lang="en" id="aff-2"><institution>Kurnakov Institute of General and Inorganic Chemistry of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>31</day><month>05</month><year>2025</year></pub-date><volume>15</volume><issue>2</issue><fpage>260</fpage><lpage>267</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Chukavin N.N., Kolmanovich D.D., Filippova A.D., Teplonogova M.A., Ivanov V.K., Popov A.L., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Чукавин Н.Н., Колманович Д.Д., Филиппова А.Д., Теплоногова М.A., Иванов В.К., Попов А.Л.</copyright-holder><copyright-holder xml:lang="en">Chukavin N.N., Kolmanovich D.D., Filippova A.D., Teplonogova M.A., Ivanov V.K., Popov A.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nanojournal.ifmo.ru/jour/article/view/53">https://nanojournal.ifmo.ru/jour/article/view/53</self-uri><abstract><p>Cerium fluoride (CeF3) nanoparticles (NPs), being a unique nanozyme and redox-active nanomaterial, show high promise for advanced biomedical applications. Doping of CeF3 NPs with the other chemical elements allow one to increase their catalytic activity, impart them new functional properties, and also to increase the efficiency of their interaction with ionizing radiation, which is important in the development of novel nanoradiosensitizers. In this article, we synthesized citrate-stabilized Ce0.75Bi0.15Tb0.1F3 nanoparticles, which demonstrate high colloidal stability, have good luminescent properties and radiation-induced redox activity. Cytotoxicity analysis of Ce0.75Bi0.15Tb0.1F3 NPs using normal and tumor cells in vitro showed the sensitivity of B16/F10 and EMTP6 tumor cell lines to the nanoparticles at high concentrations (0.5 – 1 mM). Obtained experimental results allow us to consider Ce0.75Bi0.15Tb0.1F3 nanoparticles as a possible platform for the development of a new class of nanoradiosensitizers for radiation therapy purposes.</p></abstract><trans-abstract xml:lang="ru"><p>Наночастицы фторида церия (CeF3), являясь уникальным нанозимом и редокс-активным наноматериалом, демонстрируют перспективные возможности их использования для передовых биомедицинских применений. Легирование наночастиц CeF3 другими химическими элементами позволяет повысить их каталитическую активность, придать им новые функциональные свойства, а также повысить эффективность их взаимодействия с ионизирующим излучением, что важно при разработке новых нанорадиосенсибилизаторов. В этой статье мы синтезировали цитрат-стабилизированные наночастицы Ce0.75Bi0.15Tb0.1F3, которые демонстрируют высокую коллоидную стабильность, обладают хорошими люминесцентными свойствами и радиационно-индуцированной окислительно-восстановительной активностью. Анализ цитотоксичности наночастиц Ce0.75Bi0.15Tb0.1F3 на культурах нормальных и опухолевых клеток in vitro показал чувствительность линий опухолевых клеток (B16/F10 и EMTP6) к наночастицам в высоких концентрациях (0,5-1 мМ). Полученные экспериментальные результаты позволяют рассматривать наночастицы Ce0.75Bi0.15Tb0.1F3 в качестве возможной платформы для разработки нового класса нанорадиосенсибилизаторов для целей лучевой терапии.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>наночастицы</kwd><kwd>цитотоксичность</kwd><kwd>фторид</kwd><kwd>церий</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nanoparticles</kwd><kwd>cytotoxicity</kwd><kwd>fluoride</kwd><kwd>cerium</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The work was supported by the Russian Science Foundation (project no. 22-73-10231, https://rscf.ru/project/22-73-10231/ ).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tang J.L.Y., Moonshi S.S., Ta H.T. Nanoceria: An Innovative Strategy for Cancer Treatment. Cell. Mol. Life Sci., 2023, 80, 46.</mixed-citation><mixed-citation xml:lang="en">Tang J.L.Y., Moonshi S.S., Ta H.T. Nanoceria: An Innovative Strategy for Cancer Treatment. Cell. Mol. Life Sci., 2023, 80, 46.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Xia P., Pan S., Qi Z., Fu C., Yu Z., Kong W., Chang Y., Wang K., Wu D., et al. The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics. Int. J. Nanomedicine, 2020, 15, P. 7199–7214.</mixed-citation><mixed-citation xml:lang="en">Li H., Xia P., Pan S., Qi Z., Fu C., Yu Z., Kong W., Chang Y., Wang K., Wu D., et al. The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics. Int. J. Nanomedicine, 2020, 15, P. 7199–7214.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Garzón-Manjón A., Aranda-Ramos A., Melara-Benítez B., Bensarghin I., Ros J., Ricart S., Nogués C. Simple Synthesis of Biocompatible Stable CeO2 Nanoparticles as Antioxidant Agents. Bioconjug. Chem., 2018, 29, P. 2325–2331.</mixed-citation><mixed-citation xml:lang="en">Garzón-Manjón A., Aranda-Ramos A., Melara-Benítez B., Bensarghin I., Ros J., Ricart S., Nogués C. Simple Synthesis of Biocompatible Stable CeO2 Nanoparticles as Antioxidant Agents. Bioconjug. Chem., 2018, 29, P. 2325–2331.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Banavar S., Deshpande A., Sur S., Andreescu S. Ceria Nanoparticle Theranostics: Harnessing Antioxidant Properties in Biomedicine and Beyond. J. Phys. Mater., 2021, 4, 042003</mixed-citation><mixed-citation xml:lang="en">Banavar S., Deshpande A., Sur S., Andreescu S. Ceria Nanoparticle Theranostics: Harnessing Antioxidant Properties in Biomedicine and Beyond. J. Phys. Mater., 2021, 4, 042003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Popov A.L., Shcherbakov A.B., Zholobak N.M., Baranchikov A.E., Ivanov V.K. Cerium Dioxide Nanoparticles as Third-Generation Enzymes (Nanozymes). Nanosyst. Phys. Chem. Math., 2017, 8 (6), P. 760–781.</mixed-citation><mixed-citation xml:lang="en">Popov A.L., Shcherbakov A.B., Zholobak N.M., Baranchikov A.E., Ivanov V.K. Cerium Dioxide Nanoparticles as Third-Generation Enzymes (Nanozymes). Nanosyst. Phys. Chem. Math., 2017, 8 (6), P. 760–781.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Liu H., Liu J. Self-Limited Phosphatase-Mimicking CeO2 Nanozymes. ChemNanoMat, 2020, 6, P. 947–952.</mixed-citation><mixed-citation xml:lang="en">Liu H., Liu J. Self-Limited Phosphatase-Mimicking CeO2 Nanozymes. ChemNanoMat, 2020, 6, P. 947–952.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ma Y., Tian Z., Zhai W., Qu Y. Insights on Catalytic Mechanism of CeO2 as Multiple Nanozymes. Nano Res., 2022, 15, P. 10328–10342.</mixed-citation><mixed-citation xml:lang="en">Ma Y., Tian Z., Zhai W., Qu Y. Insights on Catalytic Mechanism of CeO2 as Multiple Nanozymes. Nano Res., 2022, 15, P. 10328–10342.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Luo Q., Li Y., Huo X., Li J., Li L., Wang W., Li Y., Chen S., Song Y., Wang N. Stabilizing Ultrasmall Ceria-Cluster Nanozyme for Antibacterial and Antibiofouling Applications. Small, 2022, 18, 2107401.</mixed-citation><mixed-citation xml:lang="en">Luo Q., Li Y., Huo X., Li J., Li L., Wang W., Li Y., Chen S., Song Y., Wang N. Stabilizing Ultrasmall Ceria-Cluster Nanozyme for Antibacterial and Antibiofouling Applications. Small, 2022, 18, 2107401.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson B.C., Johnson M.E., Walker M.L., Riley K.R., Sims C.M. Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine. Antioxidants, 2016 5, 15.</mixed-citation><mixed-citation xml:lang="en">Nelson B.C., Johnson M.E., Walker M.L., Riley K.R., Sims C.M. Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine. Antioxidants, 2016 5, 15.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chukavin N.N., Filippova K.O., Ermakov A.M., Karmanova E.E., Popova N.R., Anikina V.A., Ivanova O.S., Ivanov V.K., Popov A.L. Redox-Active Cerium Fluoride Nanoparticles Selectively Modulate Cellular Response against X-Ray Irradiation In Vitro. Biomedicines, 2024, 12, 11.</mixed-citation><mixed-citation xml:lang="en">Chukavin N.N., Filippova K.O., Ermakov A.M., Karmanova E.E., Popova N.R., Anikina V.A., Ivanova O.S., Ivanov V.K., Popov A.L. Redox-Active Cerium Fluoride Nanoparticles Selectively Modulate Cellular Response against X-Ray Irradiation In Vitro. Biomedicines, 2024, 12, 11.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ermakov A., Popov A., Ermakova O., Ivanova O., Baranchikov A., Kamenskikh K., Shekunova T., Shcherbakov A., Popova N., Ivanov V. The First Inorganic Mitogens: Cerium Oxide and Cerium Fluoride Nanoparticles Stimulate Planarian Regeneration via Neoblastic Activation. Mater. Sci. Eng. C, 2019, 104, 109924.</mixed-citation><mixed-citation xml:lang="en">Ermakov A., Popov A., Ermakova O., Ivanova O., Baranchikov A., Kamenskikh K., Shekunova T., Shcherbakov A., Popova N., Ivanov V. The First Inorganic Mitogens: Cerium Oxide and Cerium Fluoride Nanoparticles Stimulate Planarian Regeneration via Neoblastic Activation. Mater. Sci. Eng. C, 2019, 104, 109924.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Filippova K.O., Ermakov A.M., Popov A.L., Ermakova O.N., Blagodatsky A.S., Chukavin N.N., Shcherbakov A.B., Baranchikov A.E., Ivanov V.K. Mitogen-like Cerium-Based Nanoparticles Protect Schmidtea Mediterranea against Severe Doses of X-Rays. Int. J. Mol. Sci., 2023, 24, 1241.</mixed-citation><mixed-citation xml:lang="en">Filippova K.O., Ermakov A.M., Popov A.L., Ermakova O.N., Blagodatsky A.S., Chukavin N.N., Shcherbakov A.B., Baranchikov A.E., Ivanov V.K. Mitogen-like Cerium-Based Nanoparticles Protect Schmidtea Mediterranea against Severe Doses of X-Rays. Int. J. Mol. Sci., 2023, 24, 1241.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobsohn L.G., Kucera C.J., James T.L., Sprinkle K.B., DiMaio J.R., Kokuoz B., Yazgan-Kukouz B., DeVol T.A., Ballato J. Preparation and Characterization of Rare Earth Doped Fluoride Nanoparticles. Materials, 2010, 3, P. 2053–2068.</mixed-citation><mixed-citation xml:lang="en">Jacobsohn L.G., Kucera C.J., James T.L., Sprinkle K.B., DiMaio J.R., Kokuoz B., Yazgan-Kukouz B., DeVol T.A., Ballato J. Preparation and Characterization of Rare Earth Doped Fluoride Nanoparticles. Materials, 2010, 3, P. 2053–2068.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Secco H. de L., Ferreira F.F., Péres L.O. Simple Preparation of Fluorescent Composite Films Based on Cerium and Europium Doped LaF3 Nanoparticles. J. Solid State Chem., 2018, 259, P. 43–47.</mixed-citation><mixed-citation xml:lang="en">Secco H. de L., Ferreira F.F., Péres L.O. Simple Preparation of Fluorescent Composite Films Based on Cerium and Europium Doped LaF3 Nanoparticles. J. Solid State Chem., 2018, 259, P. 43–47.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Huong D.T.M., Tien N.T., Vu L.V., Long N.N. Synthesis and Optical Characterization of Samarium Doped Cerium Fluoride Nanoparticles. VNU J. Sci. Math.-Phys., 2015, 31.</mixed-citation><mixed-citation xml:lang="en">Huong D.T.M., Tien N.T., Vu L.V., Long N.N. Synthesis and Optical Characterization of Samarium Doped Cerium Fluoride Nanoparticles. VNU J. Sci. Math.-Phys., 2015, 31.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Greis O., Haschke J.M. Rare Earth Fluorides. In Handbook on the Physics and Chemistry of Rare Earths, Elsevier, 1982, 5, P. 387–460.</mixed-citation><mixed-citation xml:lang="en">Greis O., Haschke J.M. Rare Earth Fluorides. In Handbook on the Physics and Chemistry of Rare Earths, Elsevier, 1982, 5, P. 387–460.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pudovkin M.S., Morozov O.A., Korableva S.L., Rakhmatullin R.M., Semashko V.V., Ginkel A.K., Rodionov A.A., Kiiamov A.G. EPR and Optical Study of Erbium-Doped CeO2 and CeO2/CeF3 Nanoparticles. Ceram. Int., 2024, 50, P. 9263–9269.</mixed-citation><mixed-citation xml:lang="en">Pudovkin M.S., Morozov O.A., Korableva S.L., Rakhmatullin R.M., Semashko V.V., Ginkel A.K., Rodionov A.A., Kiiamov A.G. EPR and Optical Study of Erbium-Doped CeO2 and CeO2/CeF3 Nanoparticles. Ceram. Int., 2024, 50, P. 9263–9269.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng Y., Xu H., Cao W., Gao W., Tang B. Cerium Fluoride Nanoparticles as a Theranostic Material for Optical Imaging of Vulnerable Atherosclerosis Plaques. J. Am. Ceram. Soc., 2023, 106, P. 2375–2383.</mixed-citation><mixed-citation xml:lang="en">Cheng Y., Xu H., Cao W., Gao W., Tang B. Cerium Fluoride Nanoparticles as a Theranostic Material for Optical Imaging of Vulnerable Atherosclerosis Plaques. J. Am. Ceram. Soc., 2023, 106, P. 2375–2383.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Ansari A.A., Malik A., Syed R., Ola M.S., Kumar A., AlGhamdi K.M., Khan S. Highly Water-Soluble Luminescent Silica-Coated Cerium Fluoride Nanoparticles Synthesis, Characterizations, and In Vitro Evaluation of Possible Cytotoxicity. ACS Omega, 2020, 5, P. 19174–19180.</mixed-citation><mixed-citation xml:lang="en">Wang J., Ansari A.A., Malik A., Syed R., Ola M.S., Kumar A., AlGhamdi K.M., Khan S. Highly Water-Soluble Luminescent Silica-Coated Cerium Fluoride Nanoparticles Synthesis, Characterizations, and In Vitro Evaluation of Possible Cytotoxicity. ACS Omega, 2020, 5, P. 19174–19180.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper D.R., Kudinov K., Tyagi P., Hill C.K., Bradforth S.E., Nadeau J.L. Photoluminescence of Cerium Fluoride and Cerium-Doped Lanthanum Fluoride Nanoparticles and Investigation of Energy Transfer to Photosensitizer Molecules. Phys. Chem. Chem. Phys., 2014, 16, P. 12441–12453.</mixed-citation><mixed-citation xml:lang="en">Cooper D.R., Kudinov K., Tyagi P., Hill C.K., Bradforth S.E., Nadeau J.L. Photoluminescence of Cerium Fluoride and Cerium-Doped Lanthanum Fluoride Nanoparticles and Investigation of Energy Transfer to Photosensitizer Molecules. Phys. Chem. Chem. Phys., 2014, 16, P. 12441–12453.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gerken L.R.H., Gerdes M.E., Pruschy M., Herrmann I.K. Prospects of Nanoparticle-Based Radioenhancement for Radiotherapy. Mater. Horiz., 2023, 10, P. 4059–4082.</mixed-citation><mixed-citation xml:lang="en">Gerken L.R.H., Gerdes M.E., Pruschy M., Herrmann I.K. Prospects of Nanoparticle-Based Radioenhancement for Radiotherapy. Mater. Horiz., 2023, 10, P. 4059–4082.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Deng J., Xu S., Hu W., Xun X., Zheng L., Su M. Tumor Targeted Stealthy and Degradable Bismuth Nanoparticles for Enhanced X-Ray Radiation Therapy of Breast Cancer. Biomaterials, 2018, 154, P. 24–33.</mixed-citation><mixed-citation xml:lang="en">Deng J., Xu S., Hu W., Xun X., Zheng L., Su M. Tumor Targeted Stealthy and Degradable Bismuth Nanoparticles for Enhanced X-Ray Radiation Therapy of Breast Cancer. Biomaterials, 2018, 154, P. 24–33.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fan W., Tang W., Lau J., Shen Z., Xie J., Shi J., Chen X. Breaking the Depth Dependence by Nanotechnology-Enhanced X-Ray-Excited Deep Cancer Theranostics. Adv. Mater., 2019, 31, 1806381.</mixed-citation><mixed-citation xml:lang="en">Fan W., Tang W., Lau J., Shen Z., Xie J., Shi J., Chen X. Breaking the Depth Dependence by Nanotechnology-Enhanced X-Ray-Excited Deep Cancer Theranostics. Adv. Mater., 2019, 31, 1806381.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yuan Z., Liu X., Ling J., Huang G., Huang J., Zhu X., He L., Chen T. In Situ-Transition Nanozyme Triggered by Tumor Microenvironment Boosts Synergistic Cancer Radio-/Chemotherapy through Disrupting Redox Homeostasis. Biomaterials, 2022, 287, 121620.</mixed-citation><mixed-citation xml:lang="en">Yuan Z., Liu X., Ling J., Huang G., Huang J., Zhu X., He L., Chen T. In Situ-Transition Nanozyme Triggered by Tumor Microenvironment Boosts Synergistic Cancer Radio-/Chemotherapy through Disrupting Redox Homeostasis. Biomaterials, 2022, 287, 121620.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S., Fang L., Ding H., Zhang Y., Li W., Liu B., Dong S., Tian B., Feng L., Yang P. Alternative Strategy to Optimize Cerium Oxide for Enhanced X-Ray-Induced Photodynamic Therapy. ACS Nano, 2022, 16, P. 20805–20819.</mixed-citation><mixed-citation xml:lang="en">Liu S., Fang L., Ding H., Zhang Y., Li W., Liu B., Dong S., Tian B., Feng L., Yang P. Alternative Strategy to Optimize Cerium Oxide for Enhanced X-Ray-Induced Photodynamic Therapy. ACS Nano, 2022, 16, P. 20805–20819.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X., Wu J., Liu R., Xiang H., Zhang W., Chang Q., Wang S., Jiang R., Zhao F., Li Q., et al. Engineering Single-Atom Iron Nanozymes with Radiation-Enhanced Self-Cascade Catalysis and Self-Supplied H2O2 for Radio-Enzymatic Therapy. ACS Nano, 2022, 16, P. 18849–18862.</mixed-citation><mixed-citation xml:lang="en">Zhu X., Wu J., Liu R., Xiang H., Zhang W., Chang Q., Wang S., Jiang R., Zhao F., Li Q., et al. Engineering Single-Atom Iron Nanozymes with Radiation-Enhanced Self-Cascade Catalysis and Self-Supplied H2O2 for Radio-Enzymatic Therapy. ACS Nano, 2022, 16, P. 18849–18862.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Bagley A.F., Ludmir E.B., Maitra A., Minsky B.D., Li Smith G., Das P., Koong A.C., Holliday E.B., Taniguchi C.M., Katz M.H.G., et al. NBTXR3, a First-in-Class Radioenhancer for Pancreatic Ductal Adenocarcinoma: Report of First Patient Experience. Clin. Transl. Radiat. Oncol., 2022, 33, P. 66–69.</mixed-citation><mixed-citation xml:lang="en">Bagley A.F., Ludmir E.B., Maitra A., Minsky B.D., Li Smith G., Das P., Koong A.C., Holliday E.B., Taniguchi C.M., Katz M.H.G., et al. NBTXR3, a First-in-Class Radioenhancer for Pancreatic Ductal Adenocarcinoma: Report of First Patient Experience. Clin. Transl. Radiat. Oncol., 2022, 33, P. 66–69.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lux F., Tran V.L., Thomas E., Dufort S., Rossetti F., Martini M., Truillet C., Doussineau T., Bort G., Denat F., et al. AGuIX® from Bench to Bedside-Transfer of an Ultrasmall Theranostic Gadolinium-Based Nanoparticle to Clinical Medicine. Br. J. Radiol., 2019, 92, 20180365.</mixed-citation><mixed-citation xml:lang="en">Lux F., Tran V.L., Thomas E., Dufort S., Rossetti F., Martini M., Truillet C., Doussineau T., Bort G., Denat F., et al. AGuIX® from Bench to Bedside-Transfer of an Ultrasmall Theranostic Gadolinium-Based Nanoparticle to Clinical Medicine. Br. J. Radiol., 2019, 92, 20180365.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ghasemi M., Turnbull T., Sebastian S., Kempson I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int. J. Mol. Sci., 2021, 22, 12827.</mixed-citation><mixed-citation xml:lang="en">Ghasemi M., Turnbull T., Sebastian S., Kempson I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int. J. Mol. Sci., 2021, 22, 12827.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Aplak E., Montfort C. von, Haasler L., Stucki D., Steckel B., Reichert A.S., Stahl W., Brenneisen P. CNP Mediated Selective Toxicity on Melanoma Cells Is Accompanied by Mitochondrial Dysfunction. PLOS ONE, 2020, 15, e0227926.</mixed-citation><mixed-citation xml:lang="en">Aplak E., Montfort C. von, Haasler L., Stucki D., Steckel B., Reichert A.S., Stahl W., Brenneisen P. CNP Mediated Selective Toxicity on Melanoma Cells Is Accompanied by Mitochondrial Dysfunction. PLOS ONE, 2020, 15, e0227926.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kolmanovich D.D., Chukavin N.N., Savintseva I.V., Mysina E.A., Popova N.R., Baranchikov A.E., Sozarukova M.M., Ivanov V.K., Popov A.L. Hybrid Polyelectrolyte Capsules Loaded with Gadolinium-Doped Cerium Oxide Nanoparticles as a Biocompatible MRI Agent for Theranostic Applications. Polymers, 2023, 15, 3840.</mixed-citation><mixed-citation xml:lang="en">Kolmanovich D.D., Chukavin N.N., Savintseva I.V., Mysina E.A., Popova N.R., Baranchikov A.E., Sozarukova M.M., Ivanov V.K., Popov A.L. Hybrid Polyelectrolyte Capsules Loaded with Gadolinium-Doped Cerium Oxide Nanoparticles as a Biocompatible MRI Agent for Theranostic Applications. Polymers, 2023, 15, 3840.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
